Page last updated: 2024-10-27

flurbiprofen and Pink Eye

flurbiprofen has been researched along with Pink Eye in 2 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

ExcerptRelevanceReference
"The flurbiprofen-treated patients experienced less severe symptoms, demonstrating maximum benefit 3 to 5 days into the drug trial with some loss of effect thereafter."2.66Hay fever treatment with combined antihistamine and cyclooxygenase-inhibiting drugs. ( Brooks, CD; Karl, KJ, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hillman, JS1
Frank, GJ1
Kheskani, MB1
Brooks, CD1
Karl, KJ1

Trials

2 trials available for flurbiprofen and Pink Eye

ArticleYear
Flurbiprofen and human intraocular inflammation.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 8

    Topics: Aqueous Humor; Cataract Extraction; Clinical Trials as Topic; Conjunctivitis; Corneal Diseases; Doub

1980
Hay fever treatment with combined antihistamine and cyclooxygenase-inhibiting drugs.
    The Journal of allergy and clinical immunology, 1988, Volume: 81, Issue:6

    Topics: Adult; Benzhydryl Compounds; Conjunctivitis; Cyclooxygenase Inhibitors; Drug Therapy, Combination; F

1988